XML 52 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Oct. 04, 2015
Sep. 28, 2014
Cash flows from operating activities:    
Net income $ 168,328 $ 94,854
Adjustments to reconcile net income to net cash provided by operating activities:    
Gain on sale of discontinued business (78,290) 0
Stock-based compensation expense 15,964 11,258
Depreciation of property, plant, and equipment 7,223 6,194
Amortization of intangible assets 3,203 2,934
Amortization of discounts or premiums on investments 536 1,596
Realized gain on sale of investments (240) (651)
Tax effect of stock option exercises (9,937) (7,178)
Change in deferred income taxes (2,134) (2,959)
Accounts receivable (31,380) (51,961)
Inventories (11,363) (6,555)
Accounts payable (6,823) 4,133
Accrued expenses (4,010) 6,221
Accrued income taxes 18,032 7,331
Deferred revenue 6,035 9,453
Other (1,086) (11,683)
Net cash provided by operating activities 74,058 62,987
Cash flows from investing activities:    
Purchases of investments (547,553) (283,982)
Maturities and sales of investments 521,464 239,396
Purchases of property, plant, and equipment (13,017) (9,078)
Cash paid for acquisition of business (1,023) 0
Cash paid for purchased technology (10,475) 0
Net proceeds from sale of discontinued business 104,496 0
Net cash provided by (used in) investing activities 53,892 (53,664)
Cash flows from financing activities:    
Issuance of common stock under stock plans 27,440 15,651
Repurchase of common stock (126,351) (35,140)
Payment of dividends (12,137) 0
Tax effect of stock option exercises 9,937 7,178
Net cash used in financing activities (101,111) (12,311)
Effect of foreign exchange rate changes on cash and cash equivalents (2,970) 523
Net change in cash and cash equivalents 23,869 (2,465)
Cash and cash equivalents at beginning of period 55,694 40,644
Cash and cash equivalents at end of period 79,563 38,179
Non-cash items related to discontinued operations:    
Depreciation and amortization expense 566 866
Capital expenditures 482 467
Stock-based compensation expense $ 1,533 $ 786